<bill session="110" type="h" number="2223" updated="2023-01-11T15:47:56Z">
  <state datetime="2007-05-08">REFERRED</state>
  <status>
    <introduced datetime="2007-05-08"/>
  </status>
  <introduced datetime="2007-05-08"/>
  <titles>
    <title type="display">To direct the Director of the Office of National Drug Control Policy, in consultation with the Attorney General and the Secretary of Health and Human Services, to conduct a study on prescription drug take-back programs, and for other purposes.</title>
    <title type="official" as="introduced">To direct the Director of the Office of National Drug Control Policy, in consultation with the Attorney General and the Secretary of Health and Human Services, to conduct a study on prescription drug take-back programs, and for other purposes.</title>
  </titles>
  <sponsor bioguide_id="P000589"/>
  <cosponsors>
    <cosponsor bioguide_id="C000059" joined="2008-02-12"/>
    <cosponsor bioguide_id="H001041" joined="2007-05-08"/>
    <cosponsor bioguide_id="L000293" joined="2007-06-26"/>
    <cosponsor bioguide_id="M001147" joined="2007-05-22"/>
    <cosponsor bioguide_id="M000933" joined="2007-06-18"/>
  </cosponsors>
  <actions>
    <action datetime="2007-05-08">
      <text>Introduced in House</text>
    </action>
    <action datetime="2007-05-08" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2007-05-08">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
    <committee code="HSIF14" name="House Energy and Commerce" subcommittee="Health" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Congressional reporting requirements"/>
    <term name="Drugs"/>
    <term name="Environmental Protection"/>
    <term name="Environmental assessment"/>
    <term name="Governmental investigations"/>
    <term name="Pharmacies"/>
    <term name="Refuse and refuse disposal"/>
  </subjects>
  <amendments/>
  <summary date="2007-08-08T18:44:53Z" status="Introduced in House">Requires the Director of the Office of National Drug Control Policy to study and report to Congress on prescription drug disposal programs in which individuals return unused prescription drugs to pharmacies or other locations, focusing on certain issues including: (1) best practices of such programs; (2) affects of such programs on pharmacies; and (3) training and infrastructure needed to ensure the success of such programs.

Requires the Administrator of the Environmental Protection Agency (EPA) to conduct a study identifying the environmental impacts of current prescription drug disposal programs and methods.</summary>
</bill>
